Cellebrite (CLBT) announced that Thomas Hogan has been appointed chief executive officer, effective immediately. Hogan had served as Cellebrite’s interim CEO since January 2025, a role that was preceded by his service as the Company’s executive chairman since August 2023. He will continue to serve on Cellebrite’s Board of Directors with Adam Clammer remaining in his role as Chairman of the Board.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLBT:
- CLBT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Cellebrite announces U.S. DOJ to sponsor platform for FedRAMP ATO
- 3 Best Stocks to Buy Now, 7/10/2025, According to Top Analysts
- Cellebrite DI: Strategic Leadership Changes and Positive Outlook Justify Buy Rating
- Cellebrite Appoints David Barter as New CFO